| Value | ₹10.00 Cr |
|---|
BSE filing, NSE: TCIIND. Summary written from the filing by ALFA Finder's alert engine.
TCI Industries Ltd: key numbers
- Share price
- ₹1,135.00
- Market cap
- ₹101.8 Cr
- Revenue (annual)
- ₹5.06 Cr
- Net profit (annual)
- ₹0.49 Cr
- P/E (TTM)
- 289.2×Sector 34.4×
- Promoter holding
- 69.53%+0.00% QoQ
- FII holding
- 0.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from TCI Industries Ltd
All →TCI Industries Board Meeting Date
TCI Industries will hold a board meeting on November 3, 2026 to approve unaudited results for the quarter and half year ended September 30, 2026. The trading window for designated persons remains closed until 48 hours after the results announcement.
TCI Industries Other Announcement
TCI Industries Ltd has filed its quarterly shareholding pattern for the quarter ended September 30, 2026. This is a routine regulatory compliance filing.
TCI Industries Promoter Selling (Off-Market): ₹0.72 Cr
Promoter group entity ABC Financial Services Private Limited sold 5,887 shares of TCI Industries Ltd in an off-market transaction valued at Rs. 0.72 Crore.
- Value
- ₹0.72 Cr
- Promoter stake change
- -0.66%
TCI Industries Promoter Buying (Off-Market): ₹0.72 Cr
Ashish Agarwal (Promoter and Director) acquired 5,887 equity shares of TCI Industries Ltd via an off-market transaction valued at Rs. 0.72 Crore.
- Value
- ₹0.72 Cr
- Promoter stake change
- +0.66%
TCI Industries Other Announcement
TCI Industries Ltd submitted its quarterly shareholding pattern as mandated by SEBI Regulation 31(1)(b) for the quarter ended March 31, 2026.
TCI Industries Other Announcement
TCI Industries Ltd submitted its quarterly shareholding pattern as of March 31, 2026, in compliance with Regulation 31 of SEBI LODR.
Other fund raise announcements
All →Sudarshan Pharma Industries Fund Raise of ₹72 Cr
Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.
- Value
- ₹72.00 Cr
Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr
Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.
- Value
- ₹68.20 Cr
Kanel Industries Fund Raise of ₹16.99 Cr
Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.
- Value
- ₹16.99 Cr
- Execution
- Rights issue opens 23 November 2026 and closes 30 November 2026
Sudarshan Pharma Industries Fund Raise
Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.
GAIL (India) Fund Raise
GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.
Gujarat Inject (Kerala) Fund Raise of ₹3 Cr
Gujarat Inject Kerala's board approved a Rs.3 Crore preferential warrant issue to public investors. Authorised capital will rise to Rs.17.63 Crore, subject to shareholder approval.
- Value
- ₹3.00 Cr